FDA inspection
Safrel Pharmaceuticals LLC: FDA inspection ending Jan 30, 2026
FDA inspection 1300468 · Official Action Indicated (OAI) · Dayton, NJ
Key facts
| Inspection ID | 1300468 |
|---|---|
| Firm | Safrel Pharmaceuticals LLC |
| FEI number | 3042030663 |
| Address | 178 Ridge Rd Ste H |
| City | Dayton |
| State | NJ |
| ZIP | 08810 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jan 30, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 730520 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data